| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/BI971956Y |
| P698 | PubMed publication ID | 9521688 |
| P50 | author | Enrico Stura | Q42710507 |
| P2093 | author name string | Johnson DL | |
| Wilson IA | |||
| Dower WJ | |||
| Jolliffe LK | |||
| Barbone FP | |||
| Farrell FX | |||
| Mulcahy LS | |||
| Wrighton NC | |||
| Livnah O | |||
| Middleton SA | |||
| Hoey K | |||
| McMahon FJ | |||
| Tullai J | |||
| Loughney DA | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | erythropoietin | Q218706 |
| P304 | page(s) | 3699-3710 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | Biochemistry | Q764876 |
| P1476 | title | Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1 | |
| P478 | volume | 37 |
| Q30809150 | A Generalizable Platform for the Photoactivation of Cell Surface Receptors |
| Q35094217 | A novel EPO receptor agonist improves glucose tolerance via glucose uptake in skeletal muscle in a mouse model of diabetes |
| Q33933699 | A screen for peptide agonists of the G-CSF receptor |
| Q30372092 | Algorithmic approaches to protein-protein interaction site prediction. |
| Q27765986 | An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation |
| Q31104720 | Biodistribution of filamentous phage peptide libraries in mice |
| Q37201897 | CNTO 530 functions as a potent EPO mimetic via unique sustained effects on bone marrow proerythroblast pools |
| Q36733103 | CNTO 530 increases expression of HbA and HbF in murine models of β-thalassemia and sickle cell anemia |
| Q36393660 | Cellular level models as tools for cytokine design |
| Q36347738 | Clonal selection and in vivo quantitation of protein interactions with protein-fragment complementation assays |
| Q33197447 | Combinatorial chemistry of beta-hairpins |
| Q35897862 | Discovery and Characterization of Nonpeptidyl Agonists of the Tissue-Protective Erythropoietin Receptor |
| Q22003959 | Efficiency of signalling through cytokine receptors depends critically on receptor orientation |
| Q37098040 | Erythropoietic agents and the elderly |
| Q34328096 | Erythropoietin |
| Q35432520 | Erythropoietin Receptor Antagonist Suppressed Ectopic Hemoglobin Synthesis in Xenografts of HeLa Cells to Promote Their Destruction |
| Q37696206 | Erythropoietin receptor response circuits |
| Q74178213 | Evaluating energetics of erythropoietin ligand binding to homodimerized receptor extracellular domains |
| Q33239436 | Evaluation of epoetin alpha (rHuEPO) and darbepoetin alpha (DARB) on human burst-colony formation (BFU-E) in culture |
| Q53212069 | Highlights from: The 9th International Congress on Hematologic Malignancies, Whistler, BC, Canada. |
| Q30663247 | Identification of a peptide that protects the human acetylcholine receptor against antigenic modulation |
| Q92223527 | Impact of Inadequate Methods and Data Analysis on Reproducibility |
| Q33712647 | In vitro selection of nucleic acids and proteins: What are we learning? |
| Q38317255 | Ligand-specific utilization of the extracellular membrane-proximal region of the gp130-related signalling receptors. |
| Q36281528 | Macromolecular docking of a three-body system: the recognition of human growth hormone by its receptor |
| Q38145338 | New G-CSF agonists for neutropenia therapy |
| Q38192002 | New treatment approaches in chronic kidney disease-associated anaemia |
| Q35720356 | Nonnatural protein-protein interaction-pair design by key residues grafting |
| Q37700912 | Peginesatide and erythropoietin stimulate similar erythropoietin receptor-mediated signal transduction and gene induction events |
| Q33800879 | Peptide phage display as a tool for drug discovery: targeting membrane receptors |
| Q30960907 | Phage display for selection of novel binding peptides |
| Q31039269 | Phage display of random peptide libraries: applications, limits, and potential |
| Q30431344 | Phage-displayed peptide libraries |
| Q61925368 | Potent Agonists of a Hematopoietic Stem Cell Cytokine Receptor, c-Mpl |
| Q33723925 | Receptor signaling: when dimerization is not enough |
| Q33786002 | Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells. |
| Q35790849 | Regulation of haematopoiesis by growth factors - emerging insights and therapies |
| Q33974356 | Rigorous assessment and integration of the sequence and structure based features to predict hot spots |
| Q34769307 | Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase |
| Q28143503 | Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide |
| Q29617413 | Signaling--2000 and beyond |
| Q33547168 | Small molecule cytokine mimetics |
| Q74315118 | Synthesis and erythropoietin receptor binding affinities of N,N-disubstituted amino acids |
| Q32044938 | Targeting growth factor and cytokine receptors with recombinant peptide libraries |
| Q28140996 | The structure, organization, activation and plasticity of the erythropoietin receptor |
| Q36509470 | Understanding cytokine and growth factor receptor activation mechanisms |
| Q78244564 | Using affinity capillary electrophoresis to study the interaction of the extracellular binding domain of erythropoietin receptor with peptides |
Search more.